Something interesting about 1-Phenylurea

Safety of 1-Phenylurea. About 1-Phenylurea, If you have any questions, you can contact Lazaro, T; Srinivasan, VM; Rahman, M; Asthagiri, A; Barkhoudarian, G; Chambless, LB; Kan, P; Rao, G; Nahed, BV; Patel, AJ or concate me.

An article Virtual education in neurosurgery during the COVID-19 pandemic WOS:000605455300007 published article about REALITY; SKILLS in [Lazaro, Tyler; Srinivasan, Visish M.; Rao, Ganesh; Patel, Akash J.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Patel, Akash J.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX USA; [Rahman, Maryam] Univ Florida, Coll Med, Gainesville, FL USA; [Asthagiri, Ashok] Providence St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA USA; [Barkhoudarian, Garni] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Chambless, Lola B.] Vanderbilt Univ, Dept Neurosurg, Sch Med, Nashville, TN USA; [Kan, Peter] Univ Texas Med Branch, Dept Neurosurg, Sch Med, Houston, TX USA; [Nahed, Brian, V] Harvard Med Sch, Dept Neurosurg, Boston, MA USA; [Patel, Akash J.] Texas Childrens Hosp, Jan & Duncan Neurol Res Inst, Houston, TX 77030 USA in 2020.0, Cited 10.0. The Name is 1-Phenylurea. Through research, I have a further understanding and discovery of 64-10-8. Safety of 1-Phenylurea

OBJECTIVE Neurosurgical education in the US has changed significantly as a consequence of the novel coronavirus (COVID-19) pandemic. Institutional social distancing requirements have resulted in many neurosurgical programs utilizing video conferencing for educational activities. However, it is unclear how or if these practices should continue after the pandemic. The objective of this study was to characterize virtual education in neurosurgery and understand how it should be utilized after COVID-19. METHODS A 24-question, 3-part online survey was administered anonymously to all 117 US neurosurgical residency programs from May 15, 2020, to June 15, 2020. Questions pertained to the current use of virtual conferencing, preferences over traditional conferences, and future inclinations. The Likert scale (1 = strongly disagree, 3 = neutral, 5 = strongly agree) was used. Comparisons were calculated using the Mann-Whitney U-test. Statistical significance was set at 0.05. RESULTS One-hundred eight responses were recorded. Overall, 38 respondents (35.2%) were attendings and 70 (64.8%) were trainees. Forty-one respondents (38.0%) indicated attending 5-6 conferences per week and 70 (64.8%) attend national virtual conferences. When considering different conference types, there was no overall preference (scores < 3) for virtual conferences over traditional conferences. In regard to future use, respondents strongly agreed that they would continue the practice at some capacity after the pandemic (median score 5). Overall, respondents agreed that virtual conferences would partially replace traditional conferences (median score 4), whereas they strongly disagreed with the complete replacement of traditional conferences (median score 1). The most common choices for the partial replacement of tradition conferences were case conferences (59/108, 55%) and board preparation (64/108, 59%). Lastly, there was a significant difference in scores for continued use of virtual conferencing in those who attend nationally sponsored conferences (median score 5, n = 70) and those who do not (median score 4, n = 38; U = 1762.50, z = 2.97, r = 0.29, p = 0.003). CONCLUSIONS Virtual conferences will likely remain an integral part of neurosurgical education after the COVID-19 pandemic has abated. Across the country, residents and faculty report a preference for continued use of virtual conferencing, especially virtual case conferences and board preparation. Some traditional conferences may even be replaced with virtual conferences, in particular those that are more didactic. Furthermore, nationally sponsored virtual conferences have a positive effect on the preferences for continued use of virtual conferences. https:// thejns.org/doi/abs/10.3171/2020.9.FOCUS20672 Safety of 1-Phenylurea. About 1-Phenylurea, If you have any questions, you can contact Lazaro, T; Srinivasan, VM; Rahman, M; Asthagiri, A; Barkhoudarian, G; Chambless, LB; Kan, P; Rao, G; Nahed, BV; Patel, AJ or concate me.

Reference:
Thiomorpholine – Wikipedia,
,Thiomorpholine | C4H9NS – PubChem